VBI Vaccines
VBIV
#10530
Rank
C$2.58 M
Marketcap
C$0.08997
Share price
0.00%
Change (1 day)
-89.63%
Change (1 year)

Earnings for VBI Vaccines (VBIV)

Earnings in 2024 (TTM): -C$0.12 Billion

According to VBI Vaccines 's latest financial reports the company's current earnings are C$9.41 Million. In 2023 the company made an earning of -C$0.13 Billion, an increase over its 2022 earnings that were of -C$0.16 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for VBI Vaccines from 1998 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -C$0.12 Billion-13.17%
2023 -C$0.13 Billion-18.06%
2022 -C$0.16 Billion62.43%
2021 -C$96.11 Million50.88%
2020 -C$63.7 Million-15.66%
2019 -C$75.53 Million-13.82%
2018 -C$87.64 Million61.32%
2017 -C$54.33 Million57.8%
2016 -C$34.43 Million-67.39%
2015 -C$0.11 Billion1527.36%
2014 -C$6.49 Million36.21%
2013 -C$4.77 Million-63.91%
2012 -C$13.2 Million-59.19%
2011 -C$32.35 Million227.23%
2010 -C$9.89 Million1741.53%
2009 -C$0.54 Million14.52%
2008 -C$0.47 Million-42.93%
2007 -C$0.83 Million21.8%
2006 -C$0.68 Million172.39%
2005 -C$0.25 Million115.38%
2004 -C$0.12 Million-42.27%
2003 -C$0.2 Million109.27%
2002 -C$0.1 Million17.89%
2001 -C$0.09 Million-369.64%
2000 C$0.02 M-69.24%
1999 C$0.09 M12.77%
1998 C$0.08 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Onconova Therapeutics
ONTX
-C$25.02 Million-78.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Myriad Genetics
MYGN
-C$0.58 Billion 404.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Curis
CRIS
-C$44.87 Million-60.77%๐Ÿ‡บ๐Ÿ‡ธ USA